Requests
0
Keep in touch with meI'm using Intch to connect with new people. Use this link to open chat with me via Intch app
Work Background
Santhera PharmaceuticalsSr. Director, US Field Medical Affairs
Jan. 2021 - Jul. 2022Atlanta, Georgia, United States
The Quadrilingual AcademyBusiness Owner
Aug. 2020Smyrna, Georgia, United States
Santhera PharmaceuticalsRegional Medical Director
Oct. 2017 - Jan. 2021Greater Atlanta Area• US Medical lead for idebenone Expanded Access Program (EAP) in Duchenne Muscular Dystrophy (DMD) • Establish relationships with key DMD centers within their region • Interact with key opinion leaders and their DMD care team, regarding importance of maintaining pulmonary function in DMD • Provide clinical and scientific information in response to inquiries about Santhera’s marketed and developmental products to physicians, other health care providers, medical centers and staff, health maintenance organizations/payers, government health organizations, and patient advocacy groups • Liaise with US investigators/sites involved with clinical trials sponsored by Santhera to provide pertinent medical information and/or assistance with qualifying/registering patients • Represent Santhera at Patient Summit/Advocacy and medical meetings of interest • Assist with the rollout of potential new initiatives, including an EAP and investigator-initiated studies • Proactively interact with other field-based personnel to ensure that Santhera maintains a strong clinical and scientific presence in the field
Horizon PharmaRegional Medical Director
Apr. 2015 - Sep. 2017Greater Memphis Area• Network and partner with important external customers, including medical thought leaders, academic institutions, large group practices, medical directors, managed care decision makers, and pharmacy directors • Identify and pair customer unmet needs with available internal resources by effectively working cross-functionally • Collaborate with Managed Markets team, to identify opportunities for scientific, and health economic information • Design, develop, and implement educational events to build product awareness and advocacy and to support and facilitate medical communications and publications • Organize clinical advisory boards and scientific meetings with investigators and identify potential new speakers • Participate in conferences, meetings, and other scientific venues relevant to Horizon products • Identify potential external clinical research collaboration opportunities and facilitate external ISTs and phase 4 trials • Monitor the competitive environment for advances and trends in our therapeutic areas, including new treatment management and new therapies, as well as competitive products and features
InterMuneManaged Care Medical Science Director
Oct. 2014 - Feb. 2015Greater Memphis Area• Advised Market Access and Healthcare Strategy Consulting vendor on the clinical presentation decks • Advocated for priority formulary status by engaging in disease state and product specific discussions and presentations with healthcare decision makers and plan administrators, including state Medicaid hearings • Educated specialty pharmacy and nurse case managers in preparation for formulary requests • Developed and executed medical plans leading to education and awareness of effective Medication Therapy Management strategies for optimal patient and provider experience • Trained and mentored new MC MSDs, leading to Esbriet® (pirfenidone) formulary acceptance with many national and regional Payors during crucial launch period
InterMuneMedical Science Director
Aug. 2011 - Feb. 2015Greater Memphis Area• Managed 6 Clinical Trial Liaisons and 3 Call Center Representatives during ASCEND enrollment & trial awareness. Responsibilities included developing job description, metrics, territory alignment, and conducting field training, leading to completion of trial enrollment before target date. • Selected as lead for trial awareness programs, including IPF patient education forums in 10 states across the Southeast to increase trial enrollment for a phase III study of pirfenidone in idiopathic pulmonary fibrosis (IPF) • Internationally trained MSDs, MC MSDs, and > 200 Commercial colleagues on IPF & pirfenidone clinical data • Selected as lead advisor for www.ipfrally.com KOL educator selection and disease state content for site and podcasts • Mentored new MSDs and develop/update territory segmentation for Field Medical Affairs • Selected to lead medical content development, and present new data at KOL Advisory Boards • Lead vendor selection, contract negotiations, and data point selection for the KOL Mapping Service • Selected as lead to develop a customer relations management (CRM) system for entry and tracking of KOL interactions, clinical intelligence, and aggregate spend for medical and commercial in Canada, US, and Latin America • Collaborated with Clinical Research colleagues to identify, evaluate, and support investigator sites • Functioned as a scientific resource and educator to identify, develop, and maintain relationships with KOLs, including IPF guideline influencers
Boehringer IngelheimSenior Medical Science Liaison, Pulmonary Field-Based Medicine
Jul. 2007 - Aug. 2011• Testified at state Medicaid hearings and conducted regional managed market presentations for Spiriva® • Provided support for internal colleagues regarding pipeline products, phase II-III studies, and NDA submission • Analyzed clinical trials and publications to leverage a competitive advantage in COPD, asthma, IPF • Evaluated Boehringer-sponsored promotional and CME programs for compliance and content • Selected as field-based medical team lead to recruit nintedanib phase III U.S. trial investigators • Identified 2 new sites and 23 investigators accepted for the nintedanib phase III studies • Transitioned from Pulmonary to CNS Women’s Sexual Health Field-Based Medicine to assist with medical support for flibanserin phase III study results and product launch (Jan 2010) • Promoted to Senior Medical Science Liaison, returned to Pulmonary Field-Based Medicine (Nov 2010)
Rutgers University and Daiichi Sankyo, Inc.Medical Affairs Fellow
Jul. 2006 - Jun. 2007•Develop and maintain a comprehensive DIU database of medical letters for Benicar® (olmesartan medoxomil), WelChol® (colesevelam HCl), Floxin® Otic (ofloxacin otic), and Evoxac® (cevimeline HCl). •Manage an off-site call center vendor to ensure expectations for internal and external customers are being met. •Initiate the facilitation of disease state background workshops (HTN, atherosclerosis, otitis media/externa) and clinical trial overviews to train new and specialty representatives during sales training meetings. •Provide medical support for Effient® (prasugrel) pre-launch educational initiatives and phase IIIB data. •Develop the clinical studies section for the updated Floxin® Otic Full Prescribing Information. •Precept Pharm.D. experiential rotation students from Ohio State and Rutgers University. •Design the Daiichi Sankyo, Inc. fellowship brochure to recruit incoming fellows. •Testify at State Medicaid Pharmacy & Therapeutics (P&T) Public Testimony hearings. •Collaborate with a Key Opinion Leader and vendor company to develop a proposal and protocol for a hypertension State Medicaid Health Outcomes project.
Intch is a Professional Networking App for the Future of WorkSee more people like Jessa on Intch
300k+ people
130+ countries
AI matching
Get Intch if you'd like to
1103465 people
21
CEO / Leadership Coach / Career Strategist / Instructional Designer / Curriculum Consultant @ Expanding Leaders
19
Teacher @ CFISD
15
Virtual Assistant
72340 people
16
Consultant/Project Manager @ Valorena Online, LLC
15
Systems Engineer @ Booz Allen Hamilton Inc
15
Public health